[1]
Olivola, M. et al. 2022. Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders: a case report. EXCLI Journal. 21, (Feb. 2022), 540–543. DOI:https://doi.org/10.17179/excli2022-4694.